Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q2 2014 · 10-Q
Revenue$193.00K$193.00K−87.1% vs Q2 2013 Net Income-$7.56M-$7.56MN/M vs Q2 2013 EPS Diluted-$0.22-$0.22N/M vs Q2 2013 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,645,000N/M Free Cash Flowderived-$4,725,000N/M Margins · derivedGross margin-202.6%−247.1 pt vs Q2 2013
Operating margin-3748.7%−3467.7 pt vs Q2 2013
Net margin-3918.1%−2921.7 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 4, 2014 · 35 d after period end